| Pfizer is a research-based, global biopharmaceutical company. Co. is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Co. collaborates with healthcare providers, governments and local communities to support and expand access to healthcare around the world. Co. provides vaccines across various ages (infants, adolescents and adults) in pneumococcal disease, meningococcal disease, tick-borne encephalitis and novel coronavirus disease of 2019 (COVID-19). Key products include: Comirnaty/BNT162b2, the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac and Trumenba.
When researching a stock like Pfizer, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from PFE Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for PFE stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the PFE 200 day moving average ("PFE 200 DMA"), while one of the most popular "shorter look-backs" is the PFE 50 day moving average ("PFE 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Pfizer.